Wine and resveratrol: Mechanisms of cancer prevention?

European Journal of Cancer Prevention

Volumn 12, Issue 5, 2003, Pages 417-425

  Bianchini, F ^a   Vainio, H ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Alcohol; Cancer prevention; Resveratrol; Wine

Indexed keywords

ANTIOXIDANT; BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450 1A1; DIETHYLSTILBESTROL; DIMETHYLBENZ[A]ANTHRACENE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; POLYCYCLIC AROMATIC HYDROCARBON; POLYPHENOL; RESVERATROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ANTIOXIDANT ACTIVITY; BASAL CELL CARCINOMA; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COLON CANCER; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; DNA DAMAGE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; WINE;

ALCOHOL DRINKING; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHEMOPREVENTION; HUMANS; MORTALITY; NEOPLASMS; RISK FACTORS; STILBENES; WINE;

EID: 0242301742     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200310000-00011     Document Type: Review

References (98)

1. Andlauer W, Kolb J, Siebert K, Furst P (2000). Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drugs Exp Clin Res 26:47-55.
2. Baldwin AS Jr (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649-683.
3. Banerjee S, Bueso-Ramos C, Aggarwal BB (2002). Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62:4945-4954.
4. Basly JP, Marre-Fournier F, Le Bail JC, et al. (2000). Estrogenic/anti-estrogenic and scavenging properties of (E)· and (Z)-resveratrol. Life Sci 66:769-777.
5. Berger K, Ajani UA, Kase CS, et al. (1999). Light-to-moderate alcohol consumption and risk of stroke among US male physicians. N Engl J Med 341:1557-1564.
6. Bhat KP, Pezzuto JM (2001). Resveratrol exhibits cytostatic and anti-estrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Cancer Res 61:6137-6144.
7. Bhat KP, Lantvit D, Christov K, et al. (2001). Estrogenic and anti-estrogenic properties of resveratrol in mammary tumour models. Cancer Res 61:7456-7463.
8. Boffetta P, Garfinkel L (1990). Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1:342-348.
9. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM (2000). Resveratrol acts as a mixed agonist/antagonist for oestrogen receptors α and β. Endocrinology 141:3657-3667.
10. Briggs NC, Levine RS, Bobo LD, et al. (2002). Wine drinking and risk of non-Hodgkin's lymphoma among men in the United States: a population-based case-control study. Am J Epidemiol 156:454-462.
11. Brown LM, Silverman DT, Pottern LM, et al. (1994). Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socio-economic factors. Cancer Causes Control 5:333-340.
12. Burkhardt S, Reiter RJ, Tan DX, et al. (2001). DNA oxidatively damaged by chromium (III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid. Int J Biochem Cell Biol 33:775-783.
13. 3. Free Radic Biol Med 26:1531-1537.
14. Cahill A, Wang X, Hoek JB (1997). Increased oxidative damage to mitochondrial DNA following chronic ethanol consumption. Biochem Biophys Res Commun 235:286-290.
15. Camargo CA Jr, Stampfer MJ, Glynn RJ, et al. (1997). Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in US male physicians. Ann Intern Med 126:372-375.
16. Chun YJ, Kim MY, Guengerich FP (1999). Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 262: 20-24.
17. Ciolino HP, Yen GC (1999). Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 56:760-767.
18. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S (1998). Chemo-preventive agent resveratrol, a natural product derived from grapes, triggers CD95 signalling-dependent apoptosis in human tumour cells. Blood 92:996-1002.
19. Cleophas TJ (1999). Wine, beer and spirits and the risk of myocardial infarction: a systematic review. Biomed Pharmacother 53:417-423.
20. Corrao G, Bagnardi V, Zambon A, Arico S (1999). Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction 94:1551-1573.
21. Criqui MH, Cowan LD, Tyroler HA, et al. (1987). Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study. Am J Epidemiol 126:629-637.
22. Damianaki A, Bakogeorgou E, Kampa M, et al. (2000). Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 78: 429-441.
23. Della Ragione FD, Cucciolla V, Borriello A, et al. (1998). Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 250:53-58.
24. Doll R, Peto R (1981). The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191-1308.
25. Ector BJ, Magee JB, Hegwood CP, Coign MJ (1996). Resveratrol concentration in muscadine berries, juice, pomace, purees, seeds, and wines. Am J Enol Vitic 47:57-62.
26. Fontecave M, Lepoivre M, Elleingand E, et al. (1998). Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421:277-279.
27. Freudenheim JL, Marshall JR, Graham S, et al. (1995). Lifetime alcohol consumption and risk of breast cancer. Nutr Cancer 23:1 -11.
28. Fuchs CS, Stampfer MJ, Colditz GA, et al. (1995). Alcohol consumption and mortality among women. N Engl J Med 332:1245-1250.
29. Fung TT, Hunter DJ, Spiegelman D, et al. (2002). Intake of alcohol and alcoholic beverages and the risk of Basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 11:1119-1122.
30. Gammon MD, Schoenberg JB, Ahsan H, et al. (1997). Tobacco, alcohol, and socio-economic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89:1277-1284.
31. Garro AJ, Lieber CS (1990). Alcohol and cancer. Annu Rev Pharmacol Toxicol 30:219-249.
32. Gehm BD, McAndrews JM, Chien PY, Jameson JL (1997). Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the oestrogen receptor. Proc Natl Acad Sci USA 94:14138-14143.
33. Gerhardsson de Verdier M, Romelsjö A, Lundberg M (1993). Alcohol and cancer of the colon and rectum. Eur J Cancer Prev 2:401-408.
34. Goldberg DM (1995). Does wine work? Clin Chem 41:14-16.
35. Goldberg DM, Yan J, Ng E, et al. (1995). A global survey of frans-resveratrol concentrations in commercial wines. Am J Enol Vitic 46:159-165.
36. Grønbæk M, Becker U, Johansen D, et al. (1998). Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. BMJ 317:844-847.
37. Grønbæk M, Becker U, Johansen D, et al. (2000). Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 133:411-419.
38. Gusman J, Malonne H, Atassi G (2001). A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22:1111-1117.
39. Holman CD, English DR, Milne E, Winter MG (1996). Meta-analysis of alcohol and all-cause mortality: a validation of NHMRC recommendations. Med J Aust 164:141-145.
40. Holmes-McNary M, Baldwin AS Jr (2000). Chemo-preventive properties of transresveratrol are associated with inhibition of activation of the IκkB kinase. Cancer Res 60:3477-3483.
41. Huang C, Ma WY, Goranson A, Dong Z (1999). Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20:237-242.
42. IARC (1988). Alcohol Drinking. Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 44. International Agency for Research on Cancer.
43. Jain MG, Ferrenc RG, Rehm JT, et al. (2000). Alcohol and breast cancer mortality in a cohort study. Breast Cancer Res Treat 64:201-209.
44. Jang M, Cai L, Udeani GO, et al. (1997). Cancer chemo-preventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220.
45. Joe AK, Liu H, Suzui M, et al. (2002). Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8:893-903.
46. Klinge CM, Risinger KE, Watts MB, et al. (2003). Estrogenic activity in white and red wine extracts. J Agric Food Chem 51:1850-1857.
47. Kuhnle G, Spencer JP, Chowrimootoo G, et al. (2000). Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 272:212-217.
48. La Vecchia C, Decarli A, Franceschi S, Pampallona S, Tognoni G (1985). Alcohol consumption and the risk of breast cancer in women. J Natl Cancer Inst 75:61-65.
49. Lê MG, Hill C, Kramar A, Flamant R (1984). Alcoholic beverage consumption and breast cancer in a French case-control study. Am J Epidemiol 120:350-357.
50. Levenson AS, Gehm BD, Pearce ST, et al. (2003). Resveratrol acts as an oestrogen receptor (ER) agonist in breast cancer cells stably transfected with ERα. Int J Cancer 104:587-596.
51. Li ZG, Hong T, Shimada Y, et al. (2002). Suppression of N-nitrosomethylbenzylamine (NMBA)-induced oesophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 23:1531-1536.
52. Longnecker MP, Orza MJ, Adams ME, et al. (1 990). A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control 1:59-68.
53. Longnecker MP (1994). Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 5:73-82.
54. Lu J, Ho CH, Ghai G, Chen KY (2001). Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts. Carcinogenesis 22:321-328.
55. Lu R, Serrero G (1999). Resveratrol, a natural product derived from grape, exhibits anti-estrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 179:297-304.
56. Mahyar-Roemer M, Katsen A, Mestres P, Roemer K (2001). Resveratrol induces colon tumour cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. Int J Cancer 94:615-622.
57. Marier JF, Vachon P, Gritsas A, et al. (2002). Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic re-circulation evidenced by a lined-rat model. J Pharmacol Ex Ther 302: 369-373.
58. Martin-Moreno JM, Boyle P, Gorgojo L, et al. (1993). Alcoholic beverage consumption and risk of breast cancer in Spain. Cancer Causes Control 4:345-353.
59. McElduff P, Dobson AJ (1997). How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. BMJ 314:1159-1164.
60. McMurtrey KD, Minn J, Pobanz K, Schultz TP (1994). Analysis of red wines for resveratrol using direct injection high-pressure liquid chromatography with electrochemical detection. J Agric Food Chem 42:2077-2080.
61. Mgbonyebi OP, Russo J, Russo IH (1998). Anti-proliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 12:865-869.
62. Mizutani K, Ikeda K, Kawai Y, Yamori Y (2001). Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 28:55-59.
63. Mollerup S, Ovrebo S, Haugen A (2001). Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int J Cancer 92:18-25.
64. Mukamal KJ, Conigrave KM, Mittleman MA, et al. (2003). Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348:109-118.
65. Narayanan BA, Narayanan NK, Re GG, Nixon DW (2003). Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer 104:204-212.
66. National Health and Medical Research Council (1992). Is There a Safe Level of Daily Consumption of Alcohol for Men and Women? Recommendations Regarding Responsible Drinking Behaviour. AGPS.
67. Nijveldt RJ, van Nood E, van Hoorn DE, et al. (2001). Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418-425.
68. Parazzini F, La Vecchia C, D'Avanzo B, et al. (1995). Alcohol and endometrial cancer risk: findings from an Italian case-control study. Nutr Cancer 23: 55-62.
69. Park JW, Choi YJ, Jang MA, et al. (2001). Chemo-preventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett 163:43-49.
70. Pezet R, Pont V, Cuenat P (1994). Method to determine resveratrol and pterostilbene in grape berries and wines using high-performance liquid chromatography and highly sensitive fluorimetric detection. J Chromatogr A663:191-197.
71. Prescott E, Gronbaek M, Becker U, Sorensen TI (1999). Alcohol intake and the risk of lung cancer: influence of type of alcoholic beverage. Am J Epidemiol 149:463-470.
72. Renaud S, de Lorgeril M (1992). Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523-1526.
73. Renaud SC, Guéguen R, Schenker J, d'Houtaud A (1998). Alcohol and mortality in middle-aged men from eastern France. Epidemiology 9:184-188.
74. Rimm EB, Giovannucci EL, Willett WC, et al. (1991). Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 338:464-468.
75. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ (1996). Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ 312:731-736.
76. Rimm EB (1996). Alcohol consumption and coronary heart disease: good habits may be more important than just good wine. Am J Epidemiol 143: 1094-1098.
77. Roger P, Sahla ME, Mäkelä S, et al. (2001). Decreased expression of oestrogen receptor β protein in proliferative pre-invasive mammary tumours. Cancer Res 61:2537-2541.
78. Schmitt E, Lehmann L, Metzler M, et al. (2002). Hormonal and genotoxic activity of resveratrol. Toxicol Lett 136:133-142.
79. Schneider Y, Vincent F, Duranton B, et al. (2000). Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett 158:85-91.
80. Sgambato A, Ardito R, Faraglia B, et al. (2001). Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat Res 496:171-180.
81. She QB, Bode AM, Ma WY, Chen NY, Dong Z (2001). Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61:1604-1610.
82. Siemann EH, Creasy LL (1992). Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 43:49-52.
83. Simanowski UA, Seitz HK, Baier B, et al. (1986). Chronic ethanol consumption selectively stimulates rectal cell proliferation in the rat. Gut 27:278-282.
84. Smith-Warner SA, Spiegelman D, Yaun SS, et al. (1998). Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 279:535-540.
85. Soleas GJ, Diamandis EP, Goldberg DM (1997). Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 11: 287-313.
86. Soleas GJ, Angelini M, Grass L, Diamandis EP, Goldberg DM (2001a). Absorption of trans-resveratrol in rats. Methods Enzymol 335:145-154.
87. Soleas GJ, Yan J, Goldberg DM (2001b). Measurement of trans-resveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection. Methods Enzymol 335:130-145.
88. Stampfer MJ, Colditz GA, Willett WC, et al. (1988). A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 319:267-273.
89. Subbaramaiah K, Chung WJ, Michaluart P, et al. (1998). Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273:21875-21882.
90. Surh YJ, Hurh YJ, Kang JY, et al. (1999.) Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukaemia (HL-60) cells. Cancer Lett 140:1-10.
91. CIP expression. Carcinogenesis 21:1619-1622.
92. Thun MJ, Peto R, Lopez AD, et al. (1997). Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med 337:1705-1714.
93. Trevisan M, Schisterman E, Mennotti A, et al. (2001). Drinking pattern and mortality: the Italian Risk Factor and Life Expectancy pooling project. Ann Epidemiol 11:312-319.
94. Tsugane S, Fahey MT, Sasaki S, Baba S (1999). Alcohol consumption and all-cause and cancer mortality among middle-aged Japanese men: seven-year follow-up of the JPHC study Cohort I. Japan Public Health Center. Am J Epidemiol 150:1201-1207.
95. Viel JF, Perarnau JM, Challier B, Faivre-Nappez I (1997). Alcoholic calories, red wine consumption and breast cancer among pre-menopausal women. Eur J Epidemiol 13:639-643.
96. 14C]-transresveratrol, a cancer chemo-preventive polyphenol, in mouse tissues after oral administration. Life Sciences 72:2219-2233.
97. Yano K, Rhoads GG, Kagan A (1977). Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med 297:405-409.
98. Zhang Y, Kreger BE, Dorgan JF, et al. (1999). Alcohol consumption and risk of breast cancer: the Framingham Study revisited. Am J Epidemiol 149: 93-101.